Literature DB >> 27486087

Factoring in the missing link.

Nilay Sethi1, Reza Sedighi Manesh2, Adam Sperling1, Scott C Bresler3, Nathan T Connell4,5, Lawrence M Tierney6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27486087      PMCID： PMC7261369          DOI： 10.1002/ajh.24501

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  20 in total

Review 1.  What is new in diagnosis and management of light chain amyloidosis?

Authors:  Giovanni Palladini; Giampaolo Merlini
Journal:  Blood       Date:  2016-04-06       Impact factor: 22.113

2.  Presurgical plasma exchange is ineffective in correcting amyloid associated factor X deficiency.

Authors:  Brad Barker; Fevzi Altuntas; Geeta Paranjape; Ravindra Sarode
Journal:  J Clin Apher       Date:  2004       Impact factor: 2.821

3.  A comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue.

Authors:  Janet A Gilbertson; Jason D Theis; Julie A Vrana; Helen Lachmann; Ashutosh Wechalekar; Carol Whelan; Philip N Hawkins; Ahmet Dogan; Julian D Gillmore
Journal:  J Clin Pathol       Date:  2015-01-30       Impact factor: 3.411

4.  Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy.

Authors:  E B Choufani; V Sanchorawala; T Ernst; K Quillen; M Skinner; D G Wright; D C Seldin
Journal:  Blood       Date:  2001-03-15       Impact factor: 22.113

5.  Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients.

Authors:  Stefan O Schönland; Ute Hegenbart; Tilmann Bochtler; Anja Mangatter; Marion Hansberg; Anthony D Ho; Peter Lohse; Christoph Röcken
Journal:  Blood       Date:  2011-11-21       Impact factor: 22.113

6.  Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.

Authors:  Giovanni Palladini; Carlo Campana; Catherine Klersy; Alessandra Balduini; Giovanbattista Vadacca; Vittorio Perfetti; Stefano Perlini; Laura Obici; Edoardo Ascari; Gianvico Melzi d'Eril; Remigio Moratti; Giampaolo Merlini
Journal:  Circulation       Date:  2003-04-28       Impact factor: 29.690

7.  Cardiac MRI in infiltrative disorders: a concise review.

Authors:  Neelima Penugonda
Journal:  Curr Cardiol Rev       Date:  2010-05

8.  Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.

Authors:  Helen J Lachmann; David R Booth; Susanne E Booth; Alison Bybee; Janet A Gilbertson; Julian D Gillmore; Mark B Pepys; Philip N Hawkins
Journal:  N Engl J Med       Date:  2002-06-06       Impact factor: 91.245

9.  Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma.

Authors:  Taxiarchis V Kourelis; Morie Gertz; Clive Zent; Martha Lacy; Robert Kyle; Prashant Kapoor; Steven Zeldenrust; Francis Buadi; Thomas Witzig; Suzanne Hayman; John Lust; Stephen Russell; Yi Lin; Vincent S Rajkumar; Shaji Kumar; Nelson Leung; David Dingli; Angela Dispenzieri
Journal:  Am J Hematol       Date:  2013-03-19       Impact factor: 10.047

10.  Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress.

Authors:  Daniel A Brenner; Mohit Jain; David R Pimentel; Bo Wang; Lawreen H Connors; Martha Skinner; Carl S Apstein; Ronglih Liao
Journal:  Circ Res       Date:  2004-03-25       Impact factor: 17.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.